AKR1B10 and lung carcinoma: Qi Wang et al. [43] found that serum expression of AKR1B10 is a diagnostic biomarker, as its expression is significantly up-regulated in patients with lung cancer that has metastasized to the brain, thus, determining the level of AKR1B10 can predict lung cancer patients with brain metastasis.